Annual Drug Patent Expirations for BYLVAY
Bylvay is a drug marketed by Albireo and is included in one NDA. It is available from one supplier. There are eight patents protecting this drug.
This drug has eigthy-eight patent family members in thirty-eight countries.
The generic ingredient in BYLVAY is odevixibat. One supplier is listed for this compound. Additional details are available on the odevixibat profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
